This test is most useful if any of these apply to you.
Most stool tests look for things that make you acutely sick: salmonella, C. difficile, parasites. This one looks for something else. Tyzzerella 4 lives in the colon of healthy people, and the question isn't whether you have it. It's how much.
Higher amounts keep turning up in people with unfavorable metabolic profiles, in women who go on to develop diabetes in pregnancy, and in adults found to have precancerous colon polyps. None of that makes this a diagnostic test. There is no standardized cutoff, and a single reading should never drive a decision on its own. But if you're already tracking your gut, it's one of the few single bacteria with real human data behind it.
Tyzzerella 4 is an organism, not a molecule your body makes. It belongs to the Lachnospiraceae family. Those are colon bacteria that ferment the fiber you can't digest yourself, and there are hundreds of kinds of them. The lab finds its DNA in your stool and reports how abundant it is relative to everything else living down there.
One caveat about the name. Most of the published research comes from 16S ribosomal RNA sequencing. That method reads one short stretch of bacterial DNA and sorts organisms into groups by how similar that stretch is. The "4" is a label from that sorting system, not a species name. Commercial stool panels that go after this organism with a different, targeted DNA method have not been checked head to head against the sequencing studies, so the number your lab reports may not line up with the research.
You don't make this yourself and you can't take it. It lives in your colon, rising or falling with what you feed it and with what the rest of the community around it is doing.
The strongest evidence is here, and it comes from a real screening population. In 1,546 asymptomatic adults aged 50 to 74 undergoing colonoscopy, 268 of whom had advanced adenomas, Tyzzerella 4 discriminated advanced adenomas better than any other single bacterium tested. Those are the precancerous polyps colonoscopy exists to remove. Best among single bacteria is still weak: on its own it scored 0.545, barely above a coin flip.
What it added matters more. Fecal immunochemical testing is the standard at-home stool screen, and it detects blood. Early polyps often don't bleed, and in that same study the blood test caught only a small minority of advanced adenomas, scoring 0.527 on its own. Layering a 13-bacteria panel that included Tyzzerella 4 onto the blood test raised combined accuracy to 0.641, and adding a validated clinical risk score built from age, sex, smoking, and family history pushed it to roughly 0.71 on a scale where 0.5 is chance and 1.0 is perfect.
A shift in gut bacteria is a different kind of signal than bleeding. It reflects a changed environment along the colon lining rather than a lesion big enough to ooze. That's why it can flag something a blood-based stool test misses. A later population-based cohort pointed the same way, finding Tyzzerella 4 to be one of two organisms that appeared to carry part of the link between lifestyle factors and high-risk adenomas. None of this substitutes for colonoscopy, and no combination tested so far comes near the accuracy of actually looking.
In a study of 196 pregnant women, Tyzzerella 4 was already enriched at 10 to 15 weeks in those who later developed gestational diabetes. Its abundance also tracked with fasting blood glucose: the more of this bacterium, the higher the fasting sugar. That's a first-trimester signal, months before the standard glucose tolerance test is usually done.
This was a case-control study, not a trial. It shows the two travel together, not that the bacterium raises blood sugar. And it hasn't been repeated at a scale that would justify using it to screen pregnancies.
In the Bogalusa Heart Study, which profiled the gut bacteria of 55 adults with high lifetime cardiovascular risk profiles and 57 with low-risk profiles, Tyzzerella 4 was clearly enriched in the high-risk group across every adjusted model. A separate study of children and adolescents found Tyzzerella subgroups rising stepwise across normal weight, overweight, and obesity.
Both are snapshots in small numbers. What makes this organism worth watching is the consistent direction across unrelated conditions. It points the same way whether the outcome is heart risk, blood sugar, weight, or colon polyps. That's more typical of a general marker of an unfavorable gut environment than of a specific cause of any one disease.
Nothing published in humans shows that Tyzzerella 4 drives any of these conditions. No trial has raised or lowered it in isolation and watched what happened. The plausible alternative is the reverse: the conditions that travel with metabolic trouble, less fiber, more inflammation, a changed colon lining, create an environment where this organism does well. It may be reading the room rather than setting the temperature.
That distinction matters for what you do with a high result. Treating the number makes no sense. Treating the environment that favors it, then checking whether the number follows, does.
This is the part to understand before you order the test. It changes how much weight any one result deserves.
One high reading of a single uncommon bacterium is a hypothesis, not a finding.
Because the day-to-day swing is so large, the trajectory is the only part of this number worth much. Get a baseline. If you're changing your diet in a real way, retest in three to six months, then at least annually, always through the same lab using the same method. Switching labs mid-stream makes the comparison meaningless.
One gap matters here. The single randomized trial showing that a diet shift lowers Tyzzerella measured the genus by sequencing, in 19 adults with spinal cord injury. Whether a commercial panel aimed at Tyzzerella 4 would register that same change hasn't been tested. Retesting can tell you whether your number is moving. The link between what you changed and what the number did is inferred, not proven.
And the diet that produced that drop carries its own cost. High-protein, reduced-carbohydrate eating patterns lower butyrate, the fatty acid your bacteria make from fiber that feeds the cells lining your colon, and they thin out the organisms that produce it. Cutting fiber to nudge one exploratory bacterium downward is a bad trade on current evidence.
Two or three readings months apart, all pointing the same way, tell you something. A single spike tells you to sample again.
A high reading on its own warrants nothing more than a repeat sample. What changes the picture is a high reading together with other findings pointing the same direction.
If this is elevated and your fasting glucose, HbA1c, or fasting insulin are also drifting up, work the metabolic side directly. The bacterium is the weaker signal in that pair. The blood markers have established targets and treatments. Order those alongside this test rather than after it, so you read them together.
If it's elevated and you're at or past the age for colorectal screening, or you have a family history of colon cancer or polyps, the answer isn't more stool testing. It's a colonoscopy. A microbiome result should never delay or substitute for screening you're already due for, and a low result should never talk you out of one. Blood in your stool, unexplained weight loss, or a persistent change in bowel habits is a gastroenterology conversation now, whatever a bacterial panel says.
If it's elevated and everything else looks clean, treat it as a prompt to read the rest of your microbiome panel: overall diversity, the fatty acids your bacteria make from fiber, and a calprotectin test if inflammation is a question. One organism out of place means less than a pattern across the whole community.
Evidence-backed interventions that affect your Tyzzerella 4 level
Tyzzerella 4 is best interpreted alongside these tests.